These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 11876697

  • 1. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis.
    Robinson M, Fitzgerald S, Hegedus R, Murthy A, Jokubaitis L, FAST Trial Investigators.
    Aliment Pharmacol Ther; 2002 Mar; 16(3):445-54. PubMed ID: 11876697
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole.
    Adachi K, Hashimoto T, Hamamoto N, Hirakawa K, Niigaki M, Miyake T, Taniura H, Ono M, Kaji T, Suetsugu H, Yagi J, Komazawa Y, Mihara T, Katsube T, Fujishiro H, Shizuku T, Hattori S, Yamamoto S, Kinoshita Y.
    J Gastroenterol Hepatol; 2003 Dec; 18(12):1392-8. PubMed ID: 14675268
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO, Wilcox CM, DeVault K, Miska D, Bochenek W, Pantoprozole US Gerd Study Group B.
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2043-52. PubMed ID: 12452936
    [Abstract] [Full Text] [Related]

  • 6. Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study.
    Archimandritis AJ, Nikolopoulou V, Kouklakis G, Paraskevas E, Avgerinos A, Tsianos E, Triantafillidis JK, Hellenic Rabeprazole Study Group.
    Curr Med Res Opin; 2005 Apr; 21(4):603-10. PubMed ID: 15899110
    [Abstract] [Full Text] [Related]

  • 7. Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group.
    Dekkers CP, Beker JA, Thjodleifsson B, Gabryelewicz A, Bell NE, Humphries TJ.
    Aliment Pharmacol Ther; 1999 Jan; 13(1):49-57. PubMed ID: 9892879
    [Abstract] [Full Text] [Related]

  • 8. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
    Wit NJ, Boer WA, Geldof H, Hazelhoff B, Bergmans P, Tytgat GN, Smout AJ.
    Aliment Pharmacol Ther; 2004 Aug 15; 20(4):451-8. PubMed ID: 15298640
    [Abstract] [Full Text] [Related]

  • 9. Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus.
    Sontag SJ, Schnell TG, Chejfec G, Kurucar C, Karpf J, Levine G.
    Aliment Pharmacol Ther; 1997 Feb 15; 11(1):147-56. PubMed ID: 9042987
    [Abstract] [Full Text] [Related]

  • 10. Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States.
    Caos A, Breiter J, Perdomo C, Barth J.
    Aliment Pharmacol Ther; 2005 Aug 01; 22(3):193-202. PubMed ID: 16091056
    [Abstract] [Full Text] [Related]

  • 11. Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment.
    Bour B, Staub JL, Chousterman M, Labayle D, Nalet B, Nouel O, Pariente A, Tocque E, Bonnot-Marlier S.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):805-12. PubMed ID: 15801915
    [Abstract] [Full Text] [Related]

  • 12. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI, Goa KL.
    Drugs; 2001 Apr 01; 61(15):2327-56. PubMed ID: 11772142
    [Abstract] [Full Text] [Related]

  • 13. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
    Bytzer P, van Zanten SV, Mattsson H, Wernersson B.
    Aliment Pharmacol Ther; 2012 Oct 01; 36(7):635-43. PubMed ID: 22860764
    [Abstract] [Full Text] [Related]

  • 14. Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease.
    Bytzer P, Blum A, De Herdt D, Dubois D, Trial Investigators.
    Aliment Pharmacol Ther; 2004 Jul 15; 20(2):181-8. PubMed ID: 15233698
    [Abstract] [Full Text] [Related]

  • 15. Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment.
    Bytzer P, Morocutti A, Kennerly P, Ravic M, Miller N, ROSE Trial Investigators.
    Scand J Gastroenterol; 2006 Oct 15; 41(10):1132-40. PubMed ID: 16990197
    [Abstract] [Full Text] [Related]

  • 16. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.
    Mee AS, Rowley JL.
    Aliment Pharmacol Ther; 1996 Oct 15; 10(5):757-63. PubMed ID: 8899084
    [Abstract] [Full Text] [Related]

  • 17. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD, Markham A.
    Drugs; 1999 Oct 15; 58(4):725-42. PubMed ID: 10551440
    [Abstract] [Full Text] [Related]

  • 18. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
    Farley A, Wruble LD, Humphries TJ.
    Am J Gastroenterol; 2000 Aug 15; 95(8):1894-9. PubMed ID: 10950032
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan.
    Miwa H, Sasaki M, Furuta T, Koike T, Habu Y, Ito M, Fujiwara Y, Wada T, Nagahara A, Hongo M, Chiba T, Kinoshita Y, ACID-RELATED SYMPTOM (ARS) RESEARCH GROUP.
    Aliment Pharmacol Ther; 2007 Jul 01; 26(1):69-77. PubMed ID: 17555423
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.